Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / SRRA - Sierra Oncology to Present at Three September Investor Conferences


SRRA - Sierra Oncology to Present at Three September Investor Conferences

Sierra Oncology, Inc. (NASDAQ: SRRA), a late-stage biopharmaceutical company on a mission to deliver targeted therapies that treat rare forms of cancer, today announced the company will participate in three investor conferences in September 2021. Stephen Dilly, MBBS, PhD, President and Chief Executive Officer of Sierra Oncology will provide a company update at the HC Wainwright 23 rd Annual Global Investment Conference and the Oppenheimer Fall Healthcare Life Sciences & Med Tech Summit. He will participate in a fireside chat discussion at the 2021 Cantor Virtual Global Healthcare Conference.

Presentation Details:

Conference:
HC Wainwright 23 rd Annual Global Investment Conference
Date:
Monday, September 13, 2021
Time:
On demand viewing beginning at 7:00 am ET
Conference:
Oppenheimer Fall Healthcare Life Sciences & Med Tech Summit
Date:
Tuesday, September 21, 2021
Time:
Presentation beginning at 2:05 pm ET
Conference:
2021 Cantor Virtual Global Healthcare Conference
Date:
Tuesday, September 28, 2021
Time:
Fireside chat beginning at 4:00 pm ET

All three presentations will be webcast and available at the times noted above on the Investors section of Sierra’s corporate website in the Events & Webcast tab.

About Sierra Oncology

Sierra Oncology is a late-stage biopharmaceutical company on a mission to deliver targeted therapies that treat rare forms of cancer. We harness our deep scientific expertise to identify compounds that target the root cause of disease. Our team takes an evidence-based approach to understand the limitations of current treatments and explore new ways to change the cancer treatment paradigm. Together we are transforming promise into patient impact.

For more information, visit www.SierraOncology.com .

View source version on businesswire.com: https://www.businesswire.com/news/home/20210907005159/en/

Investor Contact
DeDe Sheel
415.732.9828
dsheel@sierraoncology.com

Media Contact
Lauren Musto
615.351.7777
lmusto@sierraoncology.com

Stock Information

Company Name: Sierra Oncology Inc.
Stock Symbol: SRRA
Market: NASDAQ
Website: sierraoncology.com

Menu

SRRA SRRA Quote SRRA Short SRRA News SRRA Articles SRRA Message Board
Get SRRA Alerts

News, Short Squeeze, Breakout and More Instantly...